Immunotherapy Is Now First-line Therapy for Some Colorectal Cancers

Pembrolizumab is the first immunotherapy drug approved as a first-line treatment for patients with certain types of colorectal cancer that can be administered without initial chemotherapy.
Source: JAMA - Category: General Medicine Source Type: research